Search

Becton Dickinson and Co

Fechado

SetorSaúde

189.69 -0.45

Visão Geral

Variação de preço das ações

24h

Atual

Mín

186.5

Máximo

190.53

Indicadores-chave

By Trading Economics

Rendimento

759M

449M

Vendas

269M

5B

P/E

Médio do Setor

31.723

57.371

EPS

3.23

Rendimento de Dividendos

2.28

Margem de lucro

9.011

Funcionários

72,000

EBITDA

-23M

686M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+0.56% upside

Dividendos

By Acuity

Rendimento de Dividendos

Médio do Setor

2.28%

2.23%

Próximos Ganhos

5 de nov. de 2026

Próxima data de dividendos

30 de set. de 2026

Próxima data de ex-dividendo

9 de set. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

4B

50B

Abertura anterior

190.14

Fecho anterior

189.69

Sentimento de Notícias

By Acuity

44%

56%

143 / 340 Ranking em Healthcare

Becton Dickinson and Co Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

24 de ago. de 2026, 19:46 UTC

Becton Dickinson is trading lower, influenced by rising oil prices and geopolitical tensions. The stock reached a session high earlier but has since declined.

21 de ago. de 2026, 23:01 UTC

Becton Dickinson shares are lower in after-market trading, following unusual activity despite a strong one-month gain and trading above the 20-day moving average.

20 de ago. de 2026, 20:06 UTC

Becton Dickinson and Co is trading higher, maintaining an upward trajectory since Wednesday's close, despite some intraday volatility. No specific news was identified.

19 de ago. de 2026, 21:01 UTC

Becton Dickinson and Co shares are lower in after-market trading, showing unusual weakness despite remaining above the 20-day moving average. No specific news was identified.

18 de ago. de 2026, 19:46 UTC

Becton Dickinson and Co shares are lower today, breaking a trend of higher daily closes amid rising Treasury yields and inflation concerns.

17 de ago. de 2026, 23:01 UTC

News

Becton Dickinson appoints Gary Sorsher as executive vice president and chief quality officer, effective September 8. Shares are higher in after-market trading.

14 de ago. de 2026, 19:36 UTC

Becton Dickinson is trading higher today, despite a reported decline in retail sales for July that raised concerns about consumer demand.

13 de ago. de 2026, 22:01 UTC

Becton Dickinson shares are lower in after-market hours, continuing a decline from Thursday's close amid overall weakness in after-hours trading.

12 de ago. de 2026, 23:46 UTC

Event

Becton Dickinson announced successful enrollment completion in the PREVENT clinical trial for Phasix™ Mesh. Shares remain roughly flat in after-market trading.

11 de ago. de 2026, 22:26 UTC

Becton Dickinson is trading lower in after-market hours, reversing an initial gain. No specific news was identified to explain this price movement.

10 de ago. de 2026, 19:43 UTC

News

Becton Dickinson reports EPS of $3.23, exceeding estimates, and updates fiscal 2026 guidance, driving shares higher amid strong health care equipment sector gains.

7 de ago. de 2026, 21:11 UTC

News

Citigroup maintained its Buy rating on Becton Dickinson and raised its price target to $204, contributing to the stock's higher after-market trading.

6 de ago. de 2026, 23:01 UTC

Becton Dickinson and Co shares are higher in after-market hours, continuing a trend of three consecutive daily gains and remaining above the 20-day moving average.

5 de ago. de 2026, 19:46 UTC

Becton Dickinson shares are lower today amid broader market declines influenced by ADP's report on private sector job growth miss for July.

4 de ago. de 2026, 23:16 UTC

Becton Dickinson shares higher in after-market trading, reflecting positive market sentiment amid falling crude oil prices and expectations of reduced inflationary pressures.

3 de ago. de 2026, 22:51 UTC

Becton Dickinson shares are lower in after-market trading, influenced by a significant downturn in the Health Care Equipment sub-sector.

31 de jul. de 2026, 19:46 UTC

Becton Dickinson is higher today, showing resilience amid rising bond yields and inflation concerns. The stock remains above its 20-day moving average.

30 de jul. de 2026, 22:51 UTC

Becton Dickinson and Co shares are lower in after-hours trading, reflecting broader weakness in the Health Care Equipment sub-sector.

29 de jul. de 2026, 23:56 UTC

Becton Dickinson and Co shares are higher in after-market hours, maintaining momentum from Wednesday's close amid uncertainty over future interest rate decisions.

28 de jul. de 2026, 20:02 UTC

News

UBS initiated coverage of Becton Dickinson with a Buy rating and $190 price target, contributing to the stock's upward movement this week.

27 de jul. de 2026, 20:06 UTC

Becton Dickinson shares are higher, reflecting strength near the upper end of their one-month range amid falling oil prices and declining Treasury yields.

24 de jul. de 2026, 19:26 UTC

Becton Dickinson and Co is trading higher, supported by gains in the Health Care Equipment sub-sector and maintaining a position above its 20-day moving average.

23 de jul. de 2026, 19:56 UTC

Becton Dickinson shares are lower, extending a five-session decline amid ongoing market concerns over corporate earnings and inflation pressures from rising oil prices.

21 de jul. de 2026, 19:36 UTC

Becton Dickinson is trading lower today, extending a trend of three consecutive daily declines. No specific news was identified to explain the movement.

20 de jul. de 2026, 20:14 UTC

Becton Dickinson remains roughly flat in after-market trading, positioned 1.12% above its 20-day moving average, but has declined for three consecutive sessions.

Comparação entre Pares

Variação de preço

Becton Dickinson and Co Previsão

Preço-alvo

By TipRanks

0.56% parte superior

Previsão para 12 meses

Média 191.8 USD  0.56%

Máximo 210 USD

Mínimo 175 USD

Com base em 10 analistas de Wall Street que oferecem metas de preço de 12 meses para Becton Dickinson and Co - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

10 ratings

5

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

143 / 340 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Becton Dickinson and Co

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
help-icon Live chat